From the foods men eat to how surgery is planned and public awareness unfolds, new research presented at the American Urological Association (AUA) Annual Meeting in Washington, DC, shows prostate ...

Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

Also previously reported, there was no benefit for extended pelvic lymphadenectomy in the overall cohort for metastasis free ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...

Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...

The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

News, features, and commentary about cancer-related issues ...